This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Novo Nordisk A/s. Active years: 2014-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2017
Title: Lars Hornum: Innovator in Inflammatory Disease Treatment
Introduction
Lars Hornum is a notable inventor based in Bagsvaerd, Denmark. He has made significant contributions to the field of medical research, particularly in the treatment of inflammatory diseases. With a total of 3 patents to his name, Hornum's work is recognized for its potential impact on healthcare.
Latest Patents
Hornum's latest patents focus on antagonistic DR3 ligands, which are crucial for the treatment of inflammatory diseases. The first patent discloses the use of these ligands to address various inflammatory conditions. The second patent reiterates the importance of antagonistic DR3 ligands in the same context, emphasizing their utility in therapeutic applications.
Career Highlights
Lars Hornum is currently associated with Novo Nordisk A/S, a leading global healthcare company. His role at Novo Nordisk allows him to collaborate with other experts in the field and contribute to innovative solutions for patients suffering from inflammatory diseases.
Collaborations
Hornum has worked alongside talented colleagues such as Mette Dahl Andersen and Peder Lisby Noerby. Their combined expertise enhances the research and development efforts at Novo Nordisk.
Conclusion
Lars Hornum's contributions to the field of inflammatory disease treatment through his patents and work at Novo Nordisk highlight his commitment to advancing medical science. His innovative approach continues to pave the way for new therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile